Literature DB >> 10873428

Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.

A K De1, K M Kodys, J Pellegrini, B Yeh, R K Furse, P Bankey, C L Miller-Graziano.   

Abstract

Depressed mitogen-induced IL-2 and IFN-gamma responses after severe mechanical or thermal injury are postulated to result from an expansion of Th2 lymphocytes with concomitant excessive production of IL-4 and/or IL-10. Here, we simultaneously assessed proliferation and Th1 (IFN-gamma) versus Th2 (IL-10, IL-4) lymphokine production in trauma patients' isolated T cells stimulated in a costimulation sufficient, antigen presenting cell independent system (anti CD3 + anti-CD4). T cells with depressed proliferation and IL-2 production simultaneously lost IL-4, IL-10, and IFN-gamma protein and mRNA responses. Exogenous IL-12 addition did not restore IFNgamma responses, but exogenous IL-2 partially restored IL-4, IFN-gamma, and IL-10 production. Although initially partially restored by exogenous IL-2 or stimulation with PMA + ionomycin, patient T cells with persisting anergy progressively lost even these lymphokine and proliferative responses. Development of global T cell anergy was not a result of lost T cell viability or protein synthesis, since it corresponded to predominance of anergic T cells with upregulated expression of CD11b, but downregulated CD28 and CD3 expression. Thus, the subset of posttrauma patients whose isolated T cells become unresponsive experienced progressively worsening global anergy, mediated not by an increased production of Th2 lymphokines, but possibly by T cell incapacity to be activated through TCR triggering or Ca(2+) mobilization. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873428     DOI: 10.1006/clim.2000.4879

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  34 in total

Review 1.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

2.  Arginase activity and CD3ζ expression after major surgery.

Authors:  Miguel Ángel Palomero Rodríguez; Rósula García Navas; Yolanda Laporta Báez; Jesús de Vicente Sánchez; Jose Carlos Moyano Maza; Jose María Rodríguez López; Maria Pilar Sánchez Conde; Faustino Mollinedo
Journal:  Intensive Care Med       Date:  2015-03-05       Impact factor: 17.440

3.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

Review 4.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

5.  Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity.

Authors:  Malcolm P MacConmara; Adrian A Maung; Satoshi Fujimi; Ann M McKenna; Adam Delisle; Peter H Lapchak; Selwyn Rogers; James A Lederer; John A Mannick
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

6.  Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice.

Authors:  Manabu Kinoshita; Shuhji Seki; Satoshi Ono; Nariyoshi Shinomiya; Hoshio Hiraide
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 7.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

8.  Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients.

Authors:  Thomas Murphy; Hugh Paterson; Selwyn Rogers; John A Mannick; James A Lederer
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

Review 9.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

10.  Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection.

Authors:  Julia K Bohannon; Weihua Cui; Tracy Toliver-Kinsky
Journal:  BMC Immunol       Date:  2009-08-28       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.